New study tests if gene testing can improve metastatic breast cancer care

NCT ID NCT03769415

First seen Jan 31, 2026 · Last updated May 16, 2026 · Updated 14 times

Summary

This study looks at whether giving doctors extra genetic information about a patient's metastatic breast cancer helps them choose better treatments. About 500 adults with metastatic breast cancer will join. Doctors will get a special test result (PAM50) that shows the tumor's molecular subtype, and researchers will see if this changes their treatment plan.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • UNC Lineberger Comprehensive Cancer Center

    RECRUITING

    Chapel Hill, North Carolina, 27599, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • UNC Rex Healthcare

    RECRUITING

    Raleigh, North Carolina, 27607, United States

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.